Holen Sie sich die Stockscreener-App
12.20
11.65%
1.273
Vorhandelsmarkt:
12.39
0.187
+1.53%
Schlusskurs vom Vortag:
$10.93
Offen:
$10.92
24-Stunden-Volumen:
35,687
Relative Volume:
1.16
Marktkapitalisierung:
$57.28M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-24.77M
KGV:
-16.72
EPS:
-0.73
Netto-Cashflow:
$-17.36M
1W Leistung:
+9.35%
1M Leistung:
-4.74%
6M Leistung:
+71.82%
1J Leistung:
+74.23%
1-Tages-Spanne:
$10.51
$12.37
1-Wochen-Bereich:
$10.51
$12.37
52-Wochen-Spanne:
$4.5601
$76.00
Mink Therapeutics Inc Stock (INKT) Company Profile
Firmenname
Mink Therapeutics Inc
Sektor
Branche
Telefon
212-994-8250
Adresse
149 FIFTH AVENUE, NEW YORK
Vergleichen Sie INKT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INKT
Mink Therapeutics Inc
|
12.20 | 51.31M | 0 | -24.77M | -17.36M | -0.73 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Mink Therapeutics Inc Stock (INKT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-15 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2025-07-14 | Herabstufung | William Blair | Outperform → Mkt Perform |
Mink Therapeutics Inc Aktie (INKT) Neueste Nachrichten
Why MiNK Therapeutics Inc. stock is favored by top institutionsWeekly Trading Summary & Community Verified Trade Signals - Newser
How Mink Therapeutics Inc. (INKT) Affects Rotational Strategy Timing - news.stocktradersdaily.com
Is MiNK Therapeutics Inc. (6Q40) stock inflation resilientQuarterly Profit Report & Daily Growth Stock Tips - Newser
What downside risks could hit MiNK Therapeutics Inc. (6Q40) stockJuly 2025 Snapshot & AI Enhanced Market Trend Forecasts - Newser
MiNK Therapeutics (INKT) Stock Analysis Report | Financials & Insights - Benzinga
Why MiNK Therapeutics Inc. (6Q40) stock appeals to dividend investorsQuarterly Trade Summary & Growth Focused Entry Point Reports - Newser
Will MiNK Therapeutics Inc. (6Q40) stock recover faster than industryStock Surge & Momentum Based Trading Signals - Newser
How MiNK Therapeutics Inc. (6Q40) stock compares with tech leaders2025 Trading Volume Trends & High Accuracy Swing Entry Alerts - Newser
Published on: 2025-12-02 06:12:45 - Newser
Will MiNK Therapeutics Inc. (6Q40) stock outperform value peersMarket Activity Recap & Target Return Focused Stock Picks - Newser
MiNK Therapeutics, Inc. (NASDAQ:INKT) Receives Average Recommendation of “Hold” from Brokerages - Defense World
Why MiNK Therapeutics Inc. stock is seen as undervaluedEarnings Recap Report & Real-Time Volume Surge Alerts - moha.gov.vn
Buybacks Report: Why MiNK Therapeutics Inc. stock attracts global investorsM&A Rumor & Risk Managed Investment Signals - BỘ NỘI VỤ
(INKT) and the Role of Price-Sensitive Allocations - news.stocktradersdaily.com
MiNK Therapeutics Inc 6Q40 Stock Analysis and ForecastBull Market Opportunities & Learn From the Strategies of Institutions - earlytimes.in
MiNK Therapeutics Inc Stock Analysis and ForecastSupport Level Holds & Small Capital Trading Plans - earlytimes.in
MiNK Therapeutics announces publication of new preclinical data for MiNK-215 - MSN
How reliable is MiNK Therapeutics Inc. (6Q40) stock dividend growthEarnings Summary Report & Free Safe Capital Growth Stock Tips - newser.com
MiNK Therapeutics Advances iNKT Platform in Q3 2025 - MSN
MiNK Therapeutics Announces New Data Showing MiNK-215 Drives Potent Anti-Tumor Activity in Treatment-resistant Solid Tumors - The Manila Times
MiNK Therapeutics Announces New Data Showing MiNK-215 - GlobeNewswire
MiNK Therapeutics (NASDAQ: INKT) unveils MiNK-215 CAR-iNKT for solid tumors - Stock Titan
Why global investors buy MiNK Therapeutics Inc. (6Q40) stock - newser.com
How MiNK Therapeutics Inc. stock performs in rate cut cyclesBond Market & Community Shared Stock Ideas - newser.com
Mink Therapeutics Shares Slide After Announcing $50 Million Stock Offering - MSN
FY2025 EPS Estimate for MiNK Therapeutics Raised by Analyst - Defense World
Will MiNK Therapeutics Inc. stock see insider buyingJuly 2025 Sector Moves & Risk Managed Trade Strategies - newser.com
What’s next for MiNK Therapeutics Inc. stock priceBond Market & Verified Momentum Stock Watchlist - newser.com
Published on: 2025-11-19 15:48:22 - newser.com
Using fundamentals and technicals on MiNK Therapeutics Inc.2025 Biggest Moves & Free Safe Capital Growth Stock Tips - newser.com
Why analysts remain bullish on MiNK Therapeutics Inc. stockJuly 2025 Price Swings & Consistent Growth Equity Picks - newser.com
Is MiNK Therapeutics Inc. stock safe for conservative investors2025 Support & Resistance & Technical Confirmation Trade Alerts - newser.com
Can MiNK Therapeutics Inc. stock resist sector downturnsTrade Volume Summary & Entry Point Strategy Guides - newser.com
Finanzdaten der Mink Therapeutics Inc-Aktie (INKT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.10%
1.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):